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Abstract 
Background: Zimmermann–Laband Syndrome (ZLS) is an extremely rare autosomal dominant congenital disorder. 
It is a craniofacial malformation syndrome with predominant intraoral involvement consisting of gingival fibroma-
tosis diffusion in early development. The molecular basis of ZLS is still unknown. Although familial aggregation 
with different inheritance patterns is detected in ZLS patients, most of the cases are sporadic. 
Material and method: We report on two sibling patients with clinical manifestations of ZLS. Blood samples of both 
patients were obtained in EDTA-tubes followed by performing cytogenetic study using Cyto2.7M array.  Analysis 
of the copy number was performed using the Chromosome Analysis Suite Software (version 1.0.1, annotation file 
na 30, Affymetrix) and interpreted with recourse to the UCSC genome browser (http://genome.ucsc.edu/; Human 
Mar. 2006NCBI Build 36.1/hg18 assembly). 
Results: The array analysis revealed overlapping regions of chromosomal aberrations in both patients. We detected 
a 258-kb deletion at 3q13.13, a 89-kb duplication at 1q25.2 as well as two 67-kb duplications at 1p12 and 19q12. 
These altered regions do not contain any known genes and protein-coding sequences. 
Conclusions: In conclusion, the findings of this report revealed new chromosomal aberrations, including a deletion 
at 3q13.13 and duplications at 1q25.2, 1p12 and 19q12, in the two patients with ZLS. Such findings indicate that 
whole genome screening for genomic rearrangements is fruitful in typical and atypical patients with ZLS. 
Key words: Zimmermann-Laband syndrome, cytogenetic array, whole genome screening, chromosomal aberra-
tion, gingival fibromatosis.
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Introduction
Zimmermann-Laband syndrome, also known as La-
band’s syndrome, is a very rare genetic disorder charac-
terized by gingival fibromatosis (GF), hypo/aplastic nai-
ls and distal phalanges, abnormalities of soft cartilages 
of the nose and/or ears, hepatosplenomegaly, hyperex-
tensibility of joints, mild hirsutism, hypertrichosis and 
intellectual disability (1).  Gingival fibromatosis, which 
is involved in development of  masticatory, esthetic and 
speech problems, is the most explicit manifestation of 
ZLS. The characteristics of ZLS are highly variable and 
complicated. Both females and males equally are affec-
ted by this disease.  Gingival fibromatosis is usually pre-
sent at birth or appears shortly after. It is characterized 
by slow and progressive enlargement of the maxillary 
and mandibular gingiva (2). Hypo/aplastic nails and fa-
cial features are the distinguishing characteristics of ZLS 
from other cognate disorders (3). Whether these features 
stand for distinct etiology or rather clinical variability 
remains unknown.  Although, it has been suggested that 
the inheritance pattern of ZLS is autosomal dominant, 
its molecular basis is yet to be elucidated. Despite of the 
familial aggregation with different inheritance patterns 
found in ZLS patients, most of the cases are sporadic.
Several methods, including FISH, comparative genomic 
hybridization (aCGH) and whole-genome technology, 
have been recently applied for detection of common 
chromosomal aberrations, such as breakpoints, deletions, 
duplications, insertions and inversions. Whole-genome 
technology has provided the opportunity to identify the 
numerous previously unrecognized micro-deletion and 
micro-duplication syndromes (4).
The present study reports on two sibling children with 
atypical clinical features of ZLS as well as novel chro-
mosomal anomalies detected using Whole-genome 
2.7 M array. 
Material and Methods
A 9-year old girl was referred to the oral surgery clinic 
because of “gum overgrowth”. Prior to her referral, she 
had undergone surgical procedures, namely rectal polyp, 
renal sx due to hydrouretronephrosis and adenoid tonsi-
lectomy, when she was one, four and six years old, res-
pectively. Moreover, she had a history of small ventral 
septal defect (VSD) G>52mmhg, hepatosleenomegaly 
and growth. Her medical issues were congenital and 
recurred after three gingival surgeries performed over 
the past four years. Gingival hypertrophy (Fig. 1A, C, 
and D), telecanthus, hepatosplenomegaly, hypertrichosis 
and hypoplasia of terminal phalanges (Fig. 1B) with nail 
Fig. 1: Nine-year-old female patient with a Zimmermann–Laband syndrome phenotype. Note gingival hypertro-
phy and thick lips (A, C, and D). Nails of all fingers are hypoplastic. Absence of fingernails of the first fingers on 
the left and right hand is seen (B).
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hypoplasia were detected during physical examination. 
Her appearance was otherwise normal. Microscopic fin-
dings revealed dense hypocellular, hypovascular colla-
genous tissue with numerous bundles in all directions; 
furthermore, the surface epithelium exhibited long thin 
rete ridges which were extend deeply into the underlying 
fibrous connective tissue without any inflammation.  Her 
3-year old sister was also suffering from gingival and 
phalangeal hypertrophy (Fig. 2 B and D), in addition to 
hypertrichosis (Fig. 2A and C). They had no history of 
Fig. 2: Three-year-old female patient with a Zimmermann–Laband syndrome phenotype. Note hypertrichosis 
(A and C) and gingival hypertrophy (B). Nails of all fingers are hypoplastic are dystrophic (D). 
epilepsy and did not take any medications, such as anti-
convulsants. Their prenatal history, including the medi-
cations their mother had taken during her pregnancies, 
was not significant. Their parents and grandparents were 
cousins with insignificant medical history. Their other 
two siblings had no medical issues. Examining the gin-
gival biopsy samples obtained from both patients indi-
cated dense fibroblastic cell proliferation with numerous 
bundles in all directions in favor of gingival fibromato-
sis. The clinical manifestations and the pattern of inheri-
tance were consistent with ZLS. Cytogenetic study was 
performed to detect the possible chromosomal aberra-
tions in the patients.  In contrast to the findings of other 
ZLS-related reports, none of the patients had intellectual 
disability . 
The Ethics Committee of the Faculty of the Dentistry 
School, University of Shiraz Medical Sciences (Shiraz, 
Iran) approved the study, and the author group collected 
written, informed consent from both patients.
Results
Blood samples were obtained from both patients in ED-
TA-and sent to the Institut für Humangenetik, UNIVER-
SITÄTSKLINIKUM Schleswig-Holstein, Germany. 
DNA-extraction for Cyto2.7M array  (Affymetrix, Santa 
Clara, CA, USA) was performed according to the pro-
tocols provided by the manufacturer (Affymetrix, Santa 
Clara, CA) (http://www.affymetrix.com), Microarrays 
were washed and stained with the Fluidics Station 450 
(Affymetrix, Santa Clara, CA) and scanned using the 
Gene Chip Scanner 3000 (Affymetrix, Santa Clara, 
CA). Copy number analyses of the Cyto2.7M array was 
performed using the Chromosome Analysis Suite Sof-
tware (version 1.0.1, annotation file na 30, Affymetrix) 
and the data were interpreted with the aid of the UCSC 
genome browser (http://genome.ucsc.edu/; Human Mar. 
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2006NCBI Build 36.1/hg18 assembly). The detected 
genome regions, that were marked as significant by the 
software, were considered to be aberrant if more than 50 
altered markers were included within a window of more 
than 50kb. The distinction between pathological aberra-
tions and copy number variations (CNV) was performed 
using the Database of Genomic Variants implemented in 
the software. 
Analyses of the arrays revealed overlapping regions of 
chromosomal aberrations in both patients. We detected 
a 258-kb deletion of at 3q13.13 (hg18 coordinates chr3: 
111.204.741-111.463.070), a 89-kb duplication at 1q25.2 
(hg18 coordinates chr1: 175.712.702-175802.226) as 
well as two 67-kb duplications at 1p12 (hg18 coordi-
nates chr1: 118.948.407-119.016.322) and 19q12 (hg18 
coordinates chr19: 33.899.107-33.966.140). These alte-
red regions did not contain any known genes and pro-
tein-coding sequences.
Discussion 
Patients with genomic instability disorders generally 
display recognizable patterns of manifestations that lead 
to a clinical diagnosis (5).  ZLS is an extremely rare au-
tosomal dominant congenital disorder. It is a craniofa-
cial malformation syndrome with predominant intraoral 
involvement consisting of gingival fibromatosis diffu-
sion in early development (6). Other features of ZLS in-
clude large protruding upper lip, large facial bones and 
mandibles, strabismus, as well as enlarged phallus, fin-
gers and toes (7). The differential diagnoses of GF consist 
of pregnancy, inflammation, leukemia and exposure to 
drugs, such as phenytoin, diltiazem, cyclosporine A, vera-
pamil, and nifedipine (1). Gingival fibromatosis, which is 
the most common characteristic of ZLS, is usually present 
with hypertrichosis (8). The clinical examination revealed 
that both patients suffered from gingival and phalangeal 
problems. Although, the results of the review study con-
ducted by Castori et al. (2013) indicated that the combina-
tion of gingival hypertrophy and hypo/aplasia of the nails, 
with or without phalangeal involvement, are the most ex-
plicit characteristics of ZLS and are present in all (100%) 
patients (3), hypo/aplasia of the nails was not detected in 
one our patients. Both patients suffered from hypertricho-
sis, however, one of them had hepatosplenomegaly. Other 
commonly reported features ZLS include joint hypermo-
bility, hypertrichosis and hepatomegaly with or without 
splenomegaly (3). 
The molecular basis of ZLS is still unknown. In 2003, 
Stefanova et al. have described an apparently balanced 
reciprocal t(3;8)(p21.2;q24.3) translocation in a mother 
and daughter with ZLS (9). Moreover, an apparently 
balanced de novo t (3;17) (p14.3;q24.3) translocation 
found in a boy with ZLS has been reported by Kim et al. 
(2007). A chromosal breakpoint of 200-kb region was 
detected on chromosome 3p14.3 by FISH analysis (7). 
Kim et al. (2007) have reassessed the chromosome 3p 
breakpoint described by Stefanova et al. (2003) and re-
vised the breakpoint location to a 3.2-Mb region in chro-
mosome 3p14.3, which includes the CACNA2D3 and 
WNT5A genes. According to these results, they have 
suggested that the gene responsible for ZLS is located 
at 3p14.3. However, Hoogendijk, et al. (2006) have re-
ported a new chromosomal insertion, ins (12;8)(p11.2;-
q11.2q24.3), in a patient diagnosed with ZLS. They have 
concluded that the gene responsible for the syndrome 
lies on chromosome 8 (10). In 2013, Castori et al. have 
studied two unrelated children with full-blown charac-
teristics of ZLS and excluded chromosome imbalances 
at aCGH resolution of 75 Kb in both patients (3). In our 
study, no aberrancies were identified at the 3p14.3 which 
have previously been found in patients with the typical 
clinical features of ZLS.  None of these genes were di-
rectly implicated in any of the phenotypes of our patient, 
or has any patient been described with this specific chro-
mosomal aberrations.  We detected a deletion at 3q13.13 
and duplications at 1q25.2, 1p12 as well as 19q12.
Congenital deletions affecting 1q have rarely been re-
ported (11). Facial dysmorphology as well asconstant 
flexion of the proximal interphalangeal joints, and short 
distal phalanges and nails of fingers are correlated  with 
an additional band in 1q (12). Duplication defects of 
chromosome 1 are also rare. A newborn male with dupli-
cation in chromosome 1p.34 and multiple congenital ab-
normalities has been reported by Warden et al. (13). Our 
cytogenetical analyses revealed duplications at 1q25.2 
and 1p12 regions of both patients. Therefore, we suggest 
that not only the congenital deletions of 1q that have pre-
viously been reported as causative  facial and phalangeal 
dysmorphology but also any chromosomal aberration 
at this region, such as duplication, can result in these 
anomalies. In our previous review article, we have not 
found any cases with the same duplication as that of the 
patients of this patient.  The abnormalities detected in 
this study suggest that this region of chromosome 1p and 
1q could be involved in determining cell migration and/
or differentiation during organogenesis.
A 67-kb duplication was detected in chromosome 19q12 
of both patients. To the best of our knowledge, this is the 
first report of ZLS patients with duplication in 19q12. 
It is possible that this duplication is resulted from de-
fective ATM-dependent DNA double strand break repair 
(14), which is an active process during meiosis (15) as 
well as mitotic cell cycling, and may underlie the recent-
ly described phenomenon of “chromothripsis”. Howe-
ver, it is not clear whether the de novo duplication in 
19q12 occurred during the paternal or maternal meiosis, 
or during an early postzygotic cell division (16). 
In conclusion, the findings of the present study revea-
led new chromosomal aberrations, including a deletion 
at 3q13.13 as well as duplications at 1q25.2, 1p12 and 
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19q12, in the two sibling patients with ZLS. These fin-
dings indicate that whole genome screening for genomic 
rearrangements is useful in both typical and atypical pa-
tients with ZLS.
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